Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease
暂无分享,去创建一个
[1] Kimberly A. Reske,et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] D. Binion,et al. Clostridium difficile Enteritis: An Early Postoperative Complication in Inflammatory Bowel Disease Patients After Colectomy , 2007, Journal of Gastrointestinal Surgery.
[3] J. Heins. Clostridium difficile-associated disease. , 2006, South Dakota medicine : the journal of the South Dakota State Medical Association.
[4] Victoria J. Fraser,et al. ICD-9 Codes and Surveillance for Clostridium difficile–associated Disease , 2006, Emerging infectious diseases.
[5] D. Morgan,et al. The Burden of Gastrointestinal and Liver Diseases, 2006 , 2006, The American Journal of Gastroenterology.
[6] M. Owings,et al. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. , 2006, Emerging infectious diseases.
[7] A. Barkun,et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. , 2005, JAMA.
[8] J. Leighton,et al. The Diagnostic Yield of Stool Pathogen Studies During Relapses of Inflammatory Bowel Disease , 2004, Journal of clinical gastroenterology.
[9] Louis Valiquette,et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.
[10] D. Rampton,et al. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool , 2004, European journal of gastroenterology & hepatology.
[11] A. Huang,et al. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies , 2004, Canadian Medical Association Journal.
[12] C. Kelly,et al. Underlying Disease Severity as a Major Risk Factor for Nosocomial Clostridium difficile Diarrhea , 2002, Infection Control & Hospital Epidemiology.
[13] A. Morris,et al. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? , 2002, Archives of surgery.
[14] C. Kelly,et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] A. Sonnenberg,et al. Medical diagnoses and procedures associated with Clostridium difficile colitis , 2000, American Journal of Gastroenterology.
[16] L. Uscanga,et al. Toxic pseudomembranous colitis in a patient with ulcerative colitis. , 2000, Inflammatory bowel diseases.
[17] S. Meyers. Clostridium difficile Colitis , 1999, American Journal of Gastroenterology.
[18] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[19] M. Scheurlen,et al. Microbic Superinfection in Relapse of Inflammatory Bowel Disease , 1992, Journal of clinical gastroenterology.
[20] J. Gryboski. Clostridium difficile in Inflammatory Bowel Disease Relapse , 1991, Journal of pediatric gastroenterology and nutrition.
[21] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[22] R. Möllby,et al. Occurrence of Clostridium difficile toxin in inflammatory bowel disease. , 1983, Scandinavian journal of gastroenterology.
[23] J. Bartlett,et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. , 1978, The New England journal of medicine.